These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 29362595)
1. Protocol for a Systematic Review and Meta-Analysis of Lithium, Anticonvulsive or atypical antipsychotic Drugs for Treatment of Refractory Obsessive-Compulsive Disorder. Soleimani R; Jalali MM; Keshtkar A; Jalali SM J Med Life; 2017; 10(4):208-215. PubMed ID: 29362595 [TBL] [Abstract][Full Text] [Related]
3. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies]. Ammar G; Naja WJ; Pelissolo A Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852 [TBL] [Abstract][Full Text] [Related]
4. Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review. Sareen J; Kirshner A; Lander M; Kjernisted KD; Eleff MK; Reiss JP J Affect Disord; 2004 Oct; 82(2):167-74. PubMed ID: 15488245 [TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. Veale D; Miles S; Smallcombe N; Ghezai H; Goldacre B; Hodsoll J BMC Psychiatry; 2014 Nov; 14():317. PubMed ID: 25432131 [TBL] [Abstract][Full Text] [Related]
6. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation. Edwards SJ; Hamilton V; Nherera L; Trevor N Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258 [TBL] [Abstract][Full Text] [Related]
7. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy. Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic treatment in obsessive-compulsive disorder: a literature review. Keuneman RJ; Pokos V; Weerasundera R; Castle DJ Aust N Z J Psychiatry; 2005 May; 39(5):336-43. PubMed ID: 15860020 [TBL] [Abstract][Full Text] [Related]
9. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. Dold M; Aigner M; Lanzenberger R; Kasper S Int J Neuropsychopharmacol; 2015 May; 18(9):. PubMed ID: 25939614 [TBL] [Abstract][Full Text] [Related]
10. Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment. Hirschtritt ME; Bloch MH; Mathews CA JAMA; 2017 Apr; 317(13):1358-1367. PubMed ID: 28384832 [TBL] [Abstract][Full Text] [Related]
11. Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review. Amerio A; Odone A; Marchesi C; Ghaemi SN J Affect Disord; 2014 Sep; 166():258-63. PubMed ID: 25012439 [TBL] [Abstract][Full Text] [Related]
12. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Dold M; Aigner M; Lanzenberger R; Kasper S Int J Neuropsychopharmacol; 2013 Apr; 16(3):557-74. PubMed ID: 22932229 [TBL] [Abstract][Full Text] [Related]
13. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713 [TBL] [Abstract][Full Text] [Related]